explore -WSS

explore

author：fashion 2025-10-01 17:19:26 - browse：23983

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： VC firm RA Capital starts a new synthetic biology incubator

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

Cognito secures funding to test medical device for Alzheimer's

Commercial surrogacy can be ethical, despite pope’s claims

SAMSHA loosens regulations on methadone treatment centers

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

What we need to know about Arena Bioworks

knowledge

explore

explore

Malaria cases in Florida and Texas: Here’s what you need to know

Hospitals, health systems can help patients avoid medical debt

23andMe had bad news about my health. I wish a person had delivered it

Quicker fix for pulse oximeters urged during FDA public meeting

Hepatitis C has a cure — but many Americans still lack access to it

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Psychedelics group wrestles with new pharma identity

Cybersecurity threat forces Lurie Children's to take systems offline

The high cost of giving birth even with insurance

Marc Tessier

focus

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Vertigo drug brings hope for rare neuron disorder, Niemann

Quicker fix for pulse oximeters urged during FDA public meeting

Cybersecurity threat forces Lurie Children's to take systems offline

Biden to sign 'historic' executive order on how US military handles sexual assault cases

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

hotspot

focus

Wikipedia

entertainment